Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Evaporative Cooling Technologies for dry and humid climates

Objetivo

Vitality Vector creates efficient applications of solid desiccants in thermodynamic processes. The main company focus is towards developing and commercialization of high-efficient desiccant based technology for a variety of HVAC and atmospheric water recovery applications. Vitality Vector has been recognized by the panel of experts (venture capital and industry insiders) at the global H2O challenge, which evaluates the innovation and uniqueness, sustainability and economic viability. As well as, the management team and the value proposition

ECOOL technologies comprise two novel (patent WO2015005791 A1) evaporative cooling systems: the RIDEC for dry climates and DEC for semi-humid and humid atmospheric conditions. The RIDEC and DEC systems can generate cooling energy as effective as than any commercial model of MVC, consuming 5-10 times less of electrical energy.

The RIDEC (Regenerative indirect direct evaporative cooler) outperform traditional AC consuming 90% less electricity. Moreover, compared to existing regenerative cooling technologies, higher efficiency (20%) and a fraction of the cost, position the RIDEC at an advantage position in the path to displace inefficient vapor compressor technology. The DEC (Desiccant Evaporative Cooling) overcomes the humidity barrier for the applicability of evaporative cooling technologies. The DEC provides 70% energy savings in humid regions, that where reserved exclusively for vapor compressor technology.

ECOOL covers the need to reduce energy costs, displaces consumption at peak demand and increases its cooling efficiency when outside temperature is high. The expected market price of the RIDEC (50% less than equivalent AC unit) and DEC (similar price), on top of yearly energy savings, provide a winning value proposition. Vitallity Vector is in a position to build a healthy business model (€19.96 cumulative revenue after 5 years) and job creation (expected to grow up to 35 employees in that period).

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

SME-1 - SME instrument phase 1

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-SMEInst-2016-2017

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

VITALITY VECTOR BV
Aportación neta de la UEn
€ 50 000,00
Dirección
LELIEGRACHT 7
1016 GN AMSTERDAM
Países Bajos
Pyme
Sí
Región
West-Nederland Noord-Holland Groot-Amsterdam
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00